Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vladimir Rogovski"'
Autor:
Marina Kleopatra Boziki, Evangelia Kesidou, Paschalis Theotokis, Alexios-Fotios A. Mentis, Eleni Karafoulidou, Mikhail Melnikov, Anastasia Sviridova, Vladimir Rogovski, Alexey Boyko, Nikolaos Grigoriadis
Publikováno v:
Brain Sciences, Vol 10, Iss 4, p 234 (2020)
An increase of multiple sclerosis (MS) incidence has been reported during the last decade, and this may be connected to environmental factors. This review article aims to encapsulate the current advances targeting the study of the gut–brain axis, w
Externí odkaz:
https://doaj.org/article/6002fa86387e46d999c277fd7ccccf67
Autor:
Vladimir Rogovskii
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/9a6a7c86203347b6a7da2c2cdd745f01
Autor:
Evangelia Kesidou, Alexios-Fotios A. Mentis, Alexey Boyko, Nikolaos Grigoriadis, Marina Boziki, Anastasia Sviridova, M V Melnikov, Paschalis Theotokis, Eleni Karafoulidou, Vladimir Rogovski
Publikováno v:
Brain Sciences
Brain Sciences, Vol 10, Iss 234, p 234 (2020)
Brain Sciences, Vol 10, Iss 234, p 234 (2020)
An increase of multiple sclerosis (MS) incidence has been reported during the last decade, and this may be connected to environmental factors. This review article aims to encapsulate the current advances targeting the study of the gut–brain axis, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a94cd59d3d27dcf75e00b9b9f9f980dc
https://doi.org/10.3390/brainsci10040234
https://doi.org/10.3390/brainsci10040234
Autor:
Vladimir Rogovskii
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/edf871452092440d80b69fa3525fa208
Autor:
Vladimir Rogovskii
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/dacfba7282cb4513ac3dbfb570491fac
Autor:
Mikhail Melnikov, Svetlana Sharanova, Anastasiya Sviridova, Vladimir Rogovskii, Nina Murugina, Anna Nikolaeva, Yulia Dagil, Vladimir Murugin, Tatiana Ospelnikova, Alexey Boyko, Mikhail Pashenkov
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240305 (2020)
Glatiramer acetate (GA) is approved for the treatment of multiple sclerosis (MS). However, the mechanism of action of GA in MS is still unclear. In particular, it is not known whether GA can modulate the pro-inflammatory Th17-type immune response in
Externí odkaz:
https://doaj.org/article/faa5b240c1da436eb10222a7f1b195a2
Autor:
Mikhail Melnikov, Vladimir Rogovskii, Anastasiya Sviridova, Anna Lopatina, Mikhail Pashenkov, Alexey Boyko
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 2, p 668 (2022)
Norepinephrine is a neurotransmitter that also has an immunomodulatory effect and is involved in multiple sclerosis (MS) pathogenesis. This study aimed to clarify the role of the β2-adrenoreceptor in the norepinephrine-mediated modulation of interle
Externí odkaz:
https://doaj.org/article/98fd06560b884e55947cd6f26371c082